Di Luigi, L., Baldari, C, Pigozzi, F, Emerenziani, G. P., Gallotta, M. C., Iellamo, F, Ciminelli, E, Sgrò, P, Romanelli, F, Lenzi, A & Guidetti, L. (2008). The long-acting phosphodiesterase inhibitor Tadalafil does not influence athletes' V·O2max, aerobic, and anaerobic thresholds in normoxia. International Journal of Sports Medicine, 29 (2), 110-115. doi: 10.1055/s-2007-965131
APA-Zitierstil (7. Ausg.)Di Luigi, L., Baldari, C., Pigozzi, F., Emerenziani, G. P., Gallotta, M. C., Iellamo, F., . . . Guidetti, L. (2008). The long-acting phosphodiesterase inhibitor Tadalafil does not influence athletes' V·O2max, aerobic, and anaerobic thresholds in normoxia. International Journal of Sports Medicine, 29(2), 110-115.
Chicago-Zitierstil (17. Ausg.)Di Luigi, L., et al. "The Long-acting Phosphodiesterase Inhibitor Tadalafil Does Not Influence Athletes' V·O2max, Aerobic, and Anaerobic Thresholds in Normoxia." International Journal of Sports Medicine 29, no. 2 (2008): 110-115.
MLA-Zitierstil (9. Ausg.)Di Luigi, L., et al. "The Long-acting Phosphodiesterase Inhibitor Tadalafil Does Not Influence Athletes' V·O2max, Aerobic, and Anaerobic Thresholds in Normoxia." International Journal of Sports Medicine, vol. 29, no. 2, 2008, pp. 110-115.